Medicare Enrolled

Dr. Nicole Chiappetta, DO

Rheumatology · Bethlehem, PA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
2775 SCHOENERSVILLE RD, Bethlehem, PA 18017
6108618080
Registered in NPPES since 2005
NPI: 1275525503 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chiappetta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chiappetta? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chiappetta

Dr. Nicole Chiappetta is a rheumatology specialist in Bethlehem, PA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Chiappetta performed 86,976 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Chiappetta received a total of $3,732 from 26 pharmaceutical and/or device companies across 246 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chiappetta is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years of NPI registration ▲ Top 16% volume in PA $3,732 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
86,976
Medicare services
Top 16% in PA for rheumatology
Not available
Unique patients (not deduplicated)
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Certolizumab injection (Cimzia)
An injection of certolizumab pegol administered under the direct supervision of a physician.
52,600 $4 $21
Tocilizumab injection (Actemra) 15,480 $5 $15
Romosozumab injection (Evenity) for osteoporosis 8,190 $8 $21
Denosumab injection (Prolia/Xgeva) 7,440 $18 $48
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
940 $26 $130
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
832 $77 $220
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
354 $1 $7
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
263 $53 $145
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
192 $10 $65
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
174 $55 $149
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
115 $43 $356
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
85 $91 $285
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
78 $20 $65
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
60 $48 $148
X-ray of hand, minimum of 3 views
An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints.
53 $21 $45
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
37 $11 $46
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
27 $102 $275
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
27 $55 $172
X-ray of lower and sacral spine, 2-3 views
An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area.
17 $21 $85
X-ray of sacroiliac joint, 3 or more views
An X-ray imaging test that takes three or more pictures of the joint connecting the lower spine to the hip bone.
12 $22 $55
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.2% high complexity
97.4% medium
1.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$3,732
Total received (2018-2024)
Avg $533/year across 7 years
Top 44% in PA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
246
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$273
2023
$627
2022
$1,064
2021
$503
2020
$392
2019
$353
2018
$520

Payments by company (2024)

Amgen Inc.
$125
ABBVIE INC.
$125
SCILEX PHARMACEUTICALS INC.
$23
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,053
UCB, Inc.
$566
Celgene Corporation
$419
AbbVie Inc.
$353
ABBVIE INC.
$283
Janssen Biotech, Inc.
$235
PFIZER INC.
$194
AstraZeneca Pharmaceuticals LP
$133
GlaxoSmithKline, LLC.
$61
Actelion Pharmaceuticals US, Inc.
$52
Lilly USA, LLC
$51
Genentech USA, Inc.
$43
Takeda Pharmaceuticals U.S.A., Inc.
$41
Radius Health, Inc.
$34
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
Sobi, Inc
$25
SCILEX PHARMACEUTICALS INC.
$23
Mallinckrodt LLC
$23
Alexion Pharmaceuticals, Inc.
$18
Novartis Pharmaceuticals Corporation
$18
Horizon Therapeutics plc
$15
AbbVie, Inc.
$15
Orthogenrx Inc.
$13
Antares Pharma, Inc.
$13
Cumberland Pharmaceuticals, Inc.
$12
E.R. Squibb & Sons, L.L.C.
$11
Top 3 companies account for 54.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · Actemra · BENLYSTA · COSENTYX · Cimzia · EVENITY · Enbrel · FORTEO · GenVisc 850 · HUMIRA · Humira · IBRANCE · KINERET · KRYSTEXXA · LYRICA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENCIA · Otezla · Otrexup · REDITREX · REMICADE · RINVOQ · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STRENSIQ · TALTZ · TAVNEOS · TREMFYA · Tavneos · Tymlos · Uloric · XELJANZ · ZTLido
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a rheumatology specialist in Bethlehem?
Compare rheumatologists in the Bethlehem area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists in nearby ZIP areas
21
County median income
$86,687
Nearest hospital to ZIP centroid (approximate)
ST LUKES HOSPITAL BETHLEHEM
5.1 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Chiappetta is a mixed practice specialist, with above-average Medicare volume (top 16% in PA), with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Chiappetta experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Chiappetta performed 52,600 certolizumab injection (cimzia) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Chiappetta receive payments from pharmaceutical companies?
Yes. Dr. Chiappetta received a total of $3,732 from 26 companies across 246 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chiappetta's costs compare to other rheumatologists in Bethlehem?
Dr. Chiappetta's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chiappetta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →